CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of September 15, 2026, CGON trades at $73.58 with a market cap of $6.41B and a P/E ratio of -27.47. CGON moved -0.29% today. Year to date, CGON is +77.72%; over the trailing twelve months it is +121.33%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $92.56. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CGON news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $73.58 |
| Market Cap | $6.41B |
| P/E Ratio | -27.47 |
| EPS | $-2.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.97 |
| 52-Week Low | $14.80 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.23M |
| Net Income | $-224.38M |
| Gross Margin | 0.00% |
10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $92.56.